Zydus Lifesciences Legal & Regulatory
Zydus Lifesciences' subsidiary, ZPUI, settled an antitrust litigation case for a total payment of USD 5.9 million, without admission of wrongdoing.
- Value
- ₹55.46 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Zydus Lifesciences' subsidiary, ZPUI, settled an antitrust litigation case for a total payment of USD 5.9 million, without admission of wrongdoing.
Zydus Lifesciences received a demand for ₹108.54 Crore in deficient stamp duty and penalties. The company is evaluating legal remedies regarding the order.
Zydus Lifesciences' subsidiary ZHL secured favorable appellate orders dropping GST demands totaling ₹0.42 Crore. This significantly reduces the company's potential tax liability and penalty exposure.
Zydus Lifesciences received an appeal order upholding a ₹1.18 Crore GST demand and penalty. The company intends to file a second appeal before GSTAT.